Global forum on TB vaccine research and development. World Health Organization, June 7-8 2001, Geneva
Global forum on TB vaccine research and development. World Health Organization, June 7-8 2001, Geneva
复制标题
DOI：
10.1054/tube.2001.0308
复制
发表时间：
2001-01-01
期刊：
影响因子：
--
通讯作者：
Fruth, U.
中科院分区：
文献类型：
--
作者：
Brennan, M. J.;Fruth, U.
结核病界现在设想为高发病率和低发病率国家开发改进的结核病疫苗的转折点。随着许多可行的结核病候选疫苗现在可用于测试，在人体临床试验中的安全性和免疫原性的研究被视为未来开发用于预防结核病的有效疫苗的驱动力。
The TB community now envisions a turning point in the development of improved TB vaccines for both high and low incidence countries. With a number of viable TB vaccine candidates now available for testing, the investigation of safety and immunogenicity in human clinical trials is seen as the driving force for the future development of effective vaccines for the prevention of tuberculosis.